Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:QBTS News 7 January 2026 - 26 January 2026

D-Wave Quantum (QBTS) stock drops after hours as quantum shares wobble — what to watch next

D-Wave Quantum (QBTS) stock drops after hours as quantum shares wobble — what to watch next

D-Wave Quantum shares fell 7.4% to $23.75 in after-hours trading Monday, erasing earlier gains above $26. Other quantum-computing stocks, including IonQ and Rigetti, also dropped sharply. The declines came ahead of D-Wave’s Qubits conference in Florida this week, where investors expect updates on its product roadmap and customer progress. IonQ announced a $1.8 billion deal to acquire SkyWater Technology.
26 January 2026
··
D-Wave Quantum stock slides 5% as share-resale filing hangs over QBTS trade

D-Wave Quantum stock slides 5% as share-resale filing hangs over QBTS trade

D-Wave Quantum Inc shares fell 5.4% to $25.94 early Friday after a prospectus registered the resale of over 10.4 million shares linked to its Quantum Circuits acquisition. Trading volume topped 23 million shares. D-Wave closed the Quantum Circuits deal this week, adding gate-model technology to its offerings. Venture investors including Sequoia and ARCH are among those eligible to sell shares.
23 January 2026
··
D-Wave QBTS stock sinks as 10.4 million-share resale filing shadows Quantum Circuits deal

D-Wave QBTS stock sinks as 10.4 million-share resale filing shadows Quantum Circuits deal

D-Wave Quantum shares dropped 6.6% to $25.25 after an SEC filing showed a potential resale of over 10.4 million shares tied to its Quantum Circuits acquisition. The company closed the $250 million cash-and-stock deal on Jan. 20. Other quantum stocks, including IonQ and Rigetti, also fell sharply. Investors await updates at D-Wave’s Qubits 2026 event next week.
21 January 2026
··
D-Wave Quantum (QBTS) stock edges up as 10.4 million shares line up for resale after Quantum Circuits deal

D-Wave Quantum (QBTS) stock edges up as 10.4 million shares line up for resale after Quantum Circuits deal

D-Wave shares rose 0.5% to $27.17 Wednesday after completing its Quantum Circuits acquisition. A new filing allows former Quantum Circuits holders to sell up to 10.43 million D-Wave shares, with no proceeds going to D-Wave. Investors are watching for selling pressure and product updates at next week’s Qubits conference.
21 January 2026
···
IonQ, Rigetti and QUBT move: what’s driving quantum computing stocks into next week

IonQ, Rigetti and QUBT move: what’s driving quantum computing stocks into next week

IonQ rose 6.8% to $50.80 Friday, Rigetti gained 3.7%, and Quantum Computing Inc added 4.0% after Rosenblatt Securities initiated Buy ratings on Rigetti and QUBT. Rigetti delayed its 108-qubit system launch to late Q1 2026. Quantum Computing Inc was named stalking horse bidder for $22 million in Luminar assets. D-Wave Quantum edged up 0.5%.
17 January 2026
·····
D-Wave Quantum (QBTS) stock closes higher as insider sales filings surface ahead of holiday week

D-Wave Quantum (QBTS) stock closes higher as insider sales filings surface ahead of holiday week

D-Wave Quantum (QBTS) rose 0.5% to $28.83 Friday on heavy volume, as insider filings showed CEO Alan Baratz and other executives sold shares, mostly to cover tax withholding. The company is working to close a $550 million deal for Quantum Circuits, with terms tied to share price and an April 6 deadline. U.S. markets are closed Monday for Martin Luther King Jr. Day.
17 January 2026
··
D-Wave Quantum stock price rises after insider filings; QBTS traders eye Qubits 2026 next

D-Wave Quantum stock price rises after insider filings; QBTS traders eye Qubits 2026 next

D-Wave Quantum Inc shares rose 1.1% to $29.03 Friday after CEO Alan Baratz and CFO John Markovich disclosed tax-related “sell-to-cover” stock sales in SEC filings. The company’s $550 million Quantum Circuits acquisition remains pending antitrust approval. Trading volume reached about 34 million shares. Investors await D-Wave’s Qubits 2026 event set for Jan. 27–28.
16 January 2026
···
D-Wave Quantum (QBTS) stock slips after-hours on insider filings — what investors watch next

D-Wave Quantum (QBTS) stock slips after-hours on insider filings — what investors watch next

D-Wave Quantum shares dropped 4.7% to $28.72 in after-hours trading after SEC filings showed stock sales by CEO Alan Baratz, CFO John Markovich, and legal chief Diane Nguyen, some tied to tax withholding or preset plans. The company recently agreed to buy Quantum Circuits for $550 million in cash and stock. Traders are watching the deal timeline and the upcoming Qubits 2026 conference.
16 January 2026
··
Why D-Wave Quantum (QBTS) stock is slipping today as quantum IPO plans grab attention

Why D-Wave Quantum (QBTS) stock is slipping today as quantum IPO plans grab attention

D-Wave Quantum shares fell 0.5% to $29.99 Thursday afternoon, reversing gains from the previous session. Honeywell said Quantinuum plans to file a confidential S-1 for a potential IPO. D-Wave’s $550 million Quantum Circuits acquisition is expected to close by late January. Trading volume for D-Wave reached about 32 million shares.
15 January 2026
······
D-Wave (QBTS) stock jumps after hours as Honeywell’s Quantinuum IPO plan jolts quantum names

D-Wave (QBTS) stock jumps after hours as Honeywell’s Quantinuum IPO plan jolts quantum names

D-Wave Quantum shares rose 4.7% to $30.15 in after-hours trading Wednesday after Honeywell said its Quantinuum unit plans to file confidential IPO documents with the SEC. Other U.S. quantum stocks, including IonQ and Rigetti, also gained. D-Wave’s $550 million acquisition of Quantum Circuits is expected to close by late January, pending approvals. Traders are watching for D-Wave’s upcoming user conference and the Quantum Circuits deal.
15 January 2026
·····
Quantum computing stocks: QUBT slips as Wall Street stays split — what to watch next week

Quantum computing stocks: QUBT slips as Wall Street stays split — what to watch next week

Quantum Computing Inc (QUBT) shares fell 1.8% to $11.72 Friday, tracking declines in other U.S.-listed quantum stocks. The company expects U.S. court approval by late January for its $110 million bid to acquire Luminar Semiconductor out of bankruptcy. CEO Yuping Huang, officially appointed Jan. 1, said the focus will shift from prototyping to manufacturing. QUBT’s 12-month price target averages $17, with a consensus “hold” rating.
11 January 2026
······
D-Wave Quantum stock slides 4% into weekend — what QBTS traders watch before Monday

D-Wave Quantum stock slides 4% into weekend — what QBTS traders watch before Monday

D-Wave Quantum Inc. shares fell 4% to $28.11 Friday after a volatile session, with 46.7 million shares traded. The company agreed to buy Quantum Circuits for $550 million in cash and stock, with a deal deadline of April 6, 2026. Analyst John McPeake raised his price target to $43, citing technical advances and the acquisition. Options activity and sector declines signaled continued volatility.
11 January 2026
··
D-Wave Quantum (QBTS) stock slips premarket as $550 million Quantum Circuits deal spotlights dilution

D-Wave Quantum (QBTS) stock slips premarket as $550 million Quantum Circuits deal spotlights dilution

D-Wave Quantum shares fell 3.1% to $29.28 premarket after announcing a $550 million cash-and-stock deal to acquire Quantum Circuits. The stock portion will use a 10-day average price with a collar of $22.30 to $39.03 per share; the deal can be terminated if not closed by April 6. D-Wave expects to close in late January, pending antitrust review. Investors await updates at the Qubits 2026 conference Jan. 27-28.
9 January 2026
·
D-Wave Quantum stock (QBTS) slides after $550 million Quantum Circuits deal puts dilution in focus

D-Wave Quantum stock (QBTS) slides after $550 million Quantum Circuits deal puts dilution in focus

D-Wave Quantum shares fell 3.4% to $30.20 after announcing a $550 million deal to acquire Quantum Circuits, split between $250 million cash and $300 million in stock. The agreement uses a VWAP collar to set share count and requires antitrust and NYSE approval. The deal aims to bring superconducting gate-model systems to market in 2026. Trading volume reached 36.5 million shares.
8 January 2026
···
1 2 3

Stock Market Today

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

7 February 2026
NEW YORK, Feb 7, 2026, 12:05 (EST) — Market closed. XRP eased on Saturday, changing hands around $1.42, about 5% below Friday’s close as weekend trading amplified swings even with U.S. stock markets shut. The token moved between roughly $1.39 and $1.51. The latest dip lands after a bruising week for crypto, where sharp moves have become easier to trigger as liquidity thins out. “Reduced liquidity translates into sharper and more erratic price movements,” said Thomas Probst, a research analyst at crypto data provider Kaiko, pointing to a months-long slide in market depth — how much can trade near the
Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
Go toTop